Hap Trading, LLC Paratek Pharmaceuticals, Inc. Call Options Transaction History

Hap Trading, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 11, 2021	SELL	$6.81 - $10.93 $219,963 - $353,039	-32,300 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$6.14 - $8.31 $23,332 - $31,578	-3,800 Reduced 10.53%	32,300 $28,000
Q4 2020 Feb 16, 2021	BUY	$4.58 - $7.14 $165,338 - $257,754	36,100 New	36,100 $49,000
Q3 2020 Nov 13, 2020	SELL	$4.19 - $6.69 $42,738 - $68,238	-10,200 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$2.97 - $5.22 $30,294 - $53,244	10,200 New	10,200 $4,000
Q4 2019 Feb 11, 2020	SELL	$2.93 - $4.5 $32,523 - $49,950	-11,100 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$3.08 - $5.76 $34,188 - $63,936	11,100 New	11,100 $2,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.